Department of Immunology, University of Toronto, Toronto, Ontario M4N 3M5, Canada.
J Immunol. 2013 Aug 15;191(4):1704-15. doi: 10.4049/jimmunol.1300417. Epub 2013 Jul 12.
Differentiation of CD8 single-positive (SP) T cells is predicated by the ability of lymphocyte progenitors to integrate multiple signaling cues provided by the thymic microenvironment. In the thymus and the OP9-DL1 system for T cell development, Notch signals are required for progenitors to commit to the T cell lineage and necessary for their progression to the CD4(+)CD8(+) double-positive (DP) stage of T cell development. However, it remains unclear whether Notch is a prerequisite for the differentiation of DP cells to the CD8 SP stage of development. In this study, we demonstrate that Notch receptor-ligand interactions allow for efficient differentiation and selection of conventional CD8 T cells from bone marrow-derived hematopoietic stem cells. However, bone marrow-derived hematopoietic stem cells isolated from Itk(-/-)Rlk(-/-) mice gave rise to T cells with decreased IFN-γ production, but gained the ability to produce IL-17. We further reveal that positive and negative selection in vitro are constrained by peptide-MHC class I expressed on OP9 cells. Finally, using an MHC class I-restricted TCR-transgenic model, we show that the commitment of DP precursors to the CD8 T cell lineage is dependent on Notch signaling. Our findings further establish the requirement for Notch receptor-ligand interactions throughout T cell differentiation, including the final step of CD8 SP selection.
CD8 单阳性 (SP) T 细胞的分化取决于淋巴细胞前体细胞整合胸腺微环境提供的多种信号的能力。在胸腺和用于 T 细胞发育的 OP9-DL1 系统中,Notch 信号对于前体细胞向 T 细胞谱系的定向以及它们向 T 细胞发育的 CD4(+)CD8(+)双阳性 (DP) 阶段的进展是必需的。然而,Notch 是否是 DP 细胞向 CD8 SP 发育阶段分化的先决条件仍不清楚。在这项研究中,我们证明了 Notch 受体-配体相互作用允许从骨髓来源的造血干细胞中有效分化和选择常规 CD8 T 细胞。然而,从 Itk(-/-)Rlk(-/-)小鼠中分离的骨髓来源的造血干细胞产生的 T 细胞产生的 IFN-γ 减少,但获得了产生 IL-17 的能力。我们进一步揭示体外阳性和阴性选择受到 OP9 细胞上表达的肽-MHC 类 I 的限制。最后,使用 MHC 类 I 限制性 TCR 转基因模型,我们表明 DP 前体向 CD8 T 细胞谱系的定向依赖于 Notch 信号。我们的研究结果进一步确立了 Notch 受体-配体相互作用在整个 T 细胞分化过程中的必要性,包括 CD8 SP 选择的最后一步。